At the news
? NEUTRALIMPACT 3/10 8-K filed Jul 24, 2026 at 08:31 ET
Vir Biotechnology disclosed that CFO Jason O'Byrne will step down on August 3, 2026 to pursue another opportunity, with no disagreement cited. The company appointed Brent Sabatini, SVP and CAO, as interim principal financial officer effective the same date, and has initiated a search for a permanent successor. This is a routine executive transition with no financial impact disclosed.
- CFO Jason O'Byrne resigning effective August 3, 2026 to pursue another opportunity
- No disagreement with Vir Bio's operations, policies, or practices
- Brent Sabatini appointed interim principal financial officer effective August 3, 2026
- Sabatini will not receive any additional compensation for the interim role
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access